|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 2 237-247, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
M Prat, T Crepaldi, S Pennacchietti, F Bussolino and PM Comoglio
Institute for Cancer Research (IRCC), University of Torino, Medical School, Candiolo, Italy. mprat@hal.ircc.polito.it
Hepatocyte growth factor, also known as scatter factor, is a pleiotropic cytokine, which stimulates cell motility, invasion, proliferation, survival and morphogenesis, and induces the expression of specific genes by activating its receptor tyrosine kinase. In this work we have isolated, characterized and used as agonists two monoclonal antibodies (mAbs) directed against the extracellular domain of HGF receptor to investigate the requirements for receptor activation and for the different biological responses. The two mAbs display similar affinities, react with epitopes different from the hepatocyte growth factor binding site, and behave as either full or partial agonists. The full agonist mAb (DO-24) triggers all the biological effects elicited by hepatocyte growth factor, namely motility, proliferation, cell survival, invasion, tubulogenesis and angiogenesis. The partial agonist mAb (DN-30) induces only motility. Only the full agonist mAb is able to induce and sustain the expression of urokinase-type plasminogen activator receptor for prolonged periods of time, while both mAbs up-regulate the constitutive expression of urokinase-type plasminogen activator. Both mAbs activate receptor phosphorylation, which, being strictly dependent on mAb bivalence, requires receptor dimerization. Since simple receptor dimerization is not sufficient to trigger full biological responses, we propose that the region on the ss chain of the receptor recognized by the full agonist mAb is crucial for optimal receptor activation.
This article has been cited by other articles:
|
|
 |
|
  P. A. Zucali, M. G. Ruiz, E. Giovannetti, A. Destro, M. Varella-Garcia, K. Floor, G. L. Ceresoli, J. A. Rodriguez, I. Garassino, P. Comoglio, et al. Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors Ann. Onc., September 1, 2008; 19(9): 1605 - 1612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Lammerts van Bueren, W. K. Bleeker, A. Brannstrom, A. von Euler, M. Jansson, M. Peipp, T. Schneider-Merck, T. Valerius, J. G. J. van de Winkel, and P. W. H. I. Parren The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility PNAS, April 22, 2008; 105(16): 6109 - 6114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Martens, N.-O. Schmidt, C. Eckerich, R. Fillbrandt, M. Merchant, R. Schwall, M. Westphal, and K. Lamszus A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo. Clin. Cancer Res., October 15, 2006; 12(20): 6144 - 6152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Petrelli, P. Circosta, L. Granziero, M. Mazzone, A. Pisacane, S. Fenoglio, P. M. Comoglio, and S. Giordano Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity PNAS, March 28, 2006; 103(13): 5090 - 5095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Moog-Lutz, J. Degoutin, J. Y. Gouzi, Y. Frobert, N. B.-d. Carvalho, J. Bureau, C. Creminon, and M. Vigny Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin J. Biol. Chem., July 15, 2005; 280(28): 26039 - 26048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Conrotto, D. Valdembri, S. Corso, G. Serini, L. Tamagnone, P. M. Comoglio, F. Bussolino, and S. Giordano Sema4D induces angiogenesis through Met recruitment by Plexin B1 Blood, June 1, 2005; 105(11): 4321 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Motegi, J. Fujimoto, M. Kotani, H. Sakuraba, and T. Yamamoto ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth J. Cell Sci., July 1, 2004; 117(15): 3319 - 3329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Devarajan Has HGF met other partners? Met-independent epithelial morphogenesis induced by HGF. Focus on "Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity" Am J Physiol Cell Physiol, March 1, 2004; 286(3): C475 - C477. [Full Text] [PDF]
|
|
|
|
|
|
A. L. Pollack, G. Apodaca, and K. E. Mostov Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity Am J Physiol Cell Physiol, March 1, 2004; 286(3): C482 - C494. [Abstract] [Full Text]
|
|
|
|
|
|
J. Vadnais, G. Nault, Z. Daher, M. Amraei, Y. Dodier, I. R. Nabi, and J. Noel Autocrine Activation of the Hepatocyte Growth Factor Receptor/Met Tyrosine Kinase Induces Tumor Cell Motility by Regulating Pseudopodial Protrusion J. Biol. Chem., December 6, 2002; 277(50): 48342 - 48350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Bowden, G. E. Stoica, and A. Wellstein Anti-apoptotic Signaling of Pleiotrophin through Its Receptor, Anaplastic Lymphoma Kinase J. Biol. Chem., September 20, 2002; 277(39): 35862 - 35868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Grisendi, B. Chambraud, I. Gout, P. M. Comoglio, and T. Crepaldi Ligand-regulated Binding of FAP68 to the Hepatocyte Growth Factor Receptor J. Biol. Chem., November 30, 2001; 276(49): 46632 - 46638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. GIORDANO, A. MAFFE, T. A. WILLIAMS, S. ARTIGIANI, P. GUAL, A. BARDELLI, C. BASILICO, P. MICHIELI, and P. M. COMOGLIO Different point mutations in the met oncogene elicit distinct biological properties FASEB J, February 1, 2000; 14(2): 399 - 406. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Catizone, G. Ricci, V. Arista, A. Innocenzi, and M. Galdieri Hepatocyte Growth Factor and c-MET Are Expressed in Rat Prepuberal Testis Endocrinology, July 1, 1999; 140(7): 3106 - 3113. [Abstract] [Full Text]
|
|
|
|
|
|
J. Deakin and M Lyon Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009. [Abstract] [PDF]
|
|
